Skip to main content

Table 1 Characteristics of the patients according to preoperative use of low-dose acetylsalicylic acid (LdAA)

From: Bleeding and first-year mortality following hip fracture surgery and preoperative use of low-dose acetylsalicylic acid: an observational cohort study

 

LdAA

No LdAA

P value

 

(n = 118)

(n = 137)

 

Age, mean (SD)

84.0 (7.6)

80.8 (9.5)

< 0.01

Women, n (%)

82 (69.5)

108 (78.8)

0.11

Institutional residence, n (%)

29 (24.6)

31 (22.6)

0.77

Type of surgery (fracture), n (%)

  

0.07

   Hemiarthroplasty (cervical)

51 (43.2)

43 (31.4)*

 

   Fixation (subtrochanteric or pertrochanteric)

67 (56.8)

94 (68.6)

 

Time from admission to surgery (hrs), mean (SD)

20.1 (10.7)

19.2 (9.3)

0.51

Type of anesthesia, n (%)

   

   Spinal

113 (95.8)

136 (99.3)

0.1

   General

5 (4.2)

1 (0.7)

0.1

NSAID medication at fracture, n (%)

6 (5.1)

8 (5.8)

1.00

Medical history, n (%)

   

   Cardiovascular disease

72 (61)

56 (41)

< 0.01

   Cerebrovascular disease

16 (13.6)

3 (2.2)

< 0.01

   Hypertension

46 (39)

33 (24.1)

0.01

   Diabetes

17 (14.4)

12 (8.8)

0.17

   Renal dysfunction (serum creatinine)‡

31 (26.3)

15 (11.0)

< 0.01

   Pulmonary disease

8 (6.8)

15 (10.9)

0.28

   Rheumatoid arthritis

2 (1.7)

8 (5.8)

0.11

   Other disease

2 (1.7)

2 (1.5)

1.00

ASA score n (%)

  

0.02

   I

7 (5.9)

15 (10.9)

 

   II

54 (45.8)

81 (59.1)

 

   III

52 (44.1)

38 (27.7)

 

   IV

5 (4.2)

3 (2.2)

 

Compression bandage, n (%)

55 (47)

59 (43)

0.61

  1. *Including 1 total arthroplasty
  2. No data available for 15 patients receiving and 10 patients not receiving acetylsalicylic acid
  3. ‡ Defined as creatinine ≥105 μmol/L in males and ≥95 μmol/L in females
  4. ASA: American Society of Anesthesiologists; NSAID: non-steroidal anti-inflammatory drugs.